| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.15B | 17.32B | 17.08B | 14.46B | 11.98B | 11.33B |
| Gross Profit | 4.88B | 3.55B | 2.47B | 3.08B | 1.36B | 1.73B |
| EBITDA | 2.52B | 2.07B | 1.64B | 2.29B | 689.00M | 1.62B |
| Net Income | 2.03B | 1.59B | 1.37B | 2.52B | 597.00M | 1.38B |
Balance Sheet | ||||||
| Total Assets | 62.34B | 62.51B | 56.34B | 49.40B | 39.97B | 38.19B |
| Cash, Cash Equivalents and Short-Term Investments | 18.64B | 19.51B | 20.44B | 16.58B | 11.83B | 24.93B |
| Total Debt | 3.59B | 3.59B | 5.94B | 5.74B | 5.43B | 5.43B |
| Total Liabilities | 47.05B | 47.05B | 42.47B | 36.20B | 31.52B | 28.05B |
| Stockholders Equity | 15.29B | 15.46B | 13.88B | 13.20B | 8.44B | 10.14B |
Cash Flow | ||||||
| Free Cash Flow | 2.86B | 3.40B | 4.96B | 4.55B | 3.69B | 3.83B |
| Operating Cash Flow | 2.86B | 3.40B | 4.96B | 4.55B | 3.69B | 3.83B |
| Investing Cash Flow | -1.68B | -2.43B | -4.48B | -5.90B | -3.42B | -3.87B |
| Financing Cash Flow | -1.31B | -1.18B | -383.00M | 1.41B | -359.00M | 674.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $2.77B | 6.15 | 22.02% | ― | 22.94% | 317.95% | |
77 Outperform | $14.11B | 5.04 | 13.31% | 2.37% | -0.63% | 147.66% | |
77 Outperform | $3.16B | 5.67 | 23.38% | ― | 20.32% | 98.92% | |
75 Outperform | $14.10B | 10.22 | 9.47% | 1.76% | 18.66% | 55.67% | |
74 Outperform | $12.81B | 10.75 | 24.71% | 0.57% | -8.19% | 90.81% | |
74 Outperform | $11.14B | 7.56 | 15.14% | 1.43% | 9.07% | 45.94% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |